Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple gauze trick may prevent wrist artery blockage after heart procedure

NCT ID NCT06787287

Disease control Sponsor: Guozhe Sun Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a simple method to prevent wrist artery blockage after a common heart procedure. Over 1500 patients had their wrist artery pressed with a special thick gauze pad plus a standard device, or just the device alone. The goal was to see if the gauze method reduced artery blockages and other complications like bruising or pain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,568 people

The number who actually took part.

Started

Jul 2023

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Over 18 years old, regardless of gender; * Patients undergoing coronary intervention; * Patients with a transradial approach; * Voluntarily participate and sign informed consent; Exclusion Criteria: * Intraoperative Allen test was positive for all patients; * The intraoperative Barbeau tests were all D grade radial artery patients; * Patients with blood or liver diseases; * Patients with vascular diseases or malformations in the forearm; * Patients with a history of RAO at baseline of the radial artery on the approach; * Approach side arteriovenous fistula dialysis patients; * Patients with subclavian artery occlusive disease (definite medical history or the difference in systolic blood pressure between the two upper limbs is more than 20mmHg); * Patients who have completed coronary intervention (full heparin); * Active bleeding at the puncture site before extraction; * Systolic blood pressure greater than 180 mm Hg or diastolic blood pressure greater than 110 mm Hg at closure; * Pregnant women or patients who are trying to conceive and have family plans; * Patients whom the investigator deems inappropriate to participate in the clinical trial;

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronary artery disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

arterial occlusion Arterial Occlusive Diseases coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coronary artery disease Radial artery occlusion

Contacts and locations

Locations

  • First Hospital of China Medical University

    Shenyang, Liaoning, China, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.